Richard Sever

@cshperspectives @pathogenomenick Interesting. One category per paper or multiple?

@asiepel @pathogenomenick one only per paper (for best browsing experience)

@cshperspectives @pathogenomenick I see. Many must lie in intersection of at least two or three of these. But maybe doesn't affect trend

@asiepel @pathogenomenick yes - that’s probably true. And those categories aren’t a formal taxonomy just convenient & familiar buckets

@cshperspectives @pathogenomenick Maybe worth partitioning Evol Biol. Very broad field. In practice mostly popgen?

@cshperspectives image cut off -- and as a cell and molecular biologist, I care about that right tail...

@dallandrummond @cshperspectives not surprised that "molecular biologists" don't preprint. What are the barriers & how can they be overcome?

@eperlste @cshperspectives main barrier = awareness, competitive concerns. to overcome: post high-qual papers & show value. that's our plan.

@dallandrummond @eperlste Right. Journals emphasizing it’s OK (more to come on that..) & funders/hirers saying preprint = priority will help

@cshperspectives @dallandrummond @eperlste I think the main barrier is that the reagents are not exclusive and therefore the risk is higher

@cshperspectives @dallandrummond @eperlste genomics of 6000 people is relatively immune; biochem on My Favorite Protein is easily replicated

@stephenfloor @cshperspectives @eperlste crystallographer friends say "no way" when we talk preprints. But preprint = priority would fix.

@dallandrummond @cshperspectives @eperlste 100% agree that preprint = priority is the key. how to promote this? Funders recognize preprints?